Research Progress on Anti-Inflammatory Effects and Related Mechanisms of Astragalin
Open Access
- 19 April 2024
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (8) , 4476
Abstract
Chronic inflammation is a significant contributor to the development of cancer, cardiovascular disease, diabetes, obesity, autoimmune disease, inflammatory bowel disease, and other illnesses. In the academic field, there is a constant demand for effective methods to alleviate inflammation. Astragalin (AST), a type of flavonoid glycoside that is the primary component in several widely used traditional Chinese anti-inflammatory medications in clinical practice, has garnered attention from numerous experts and scholars. This article focuses on the anti-inflammatory effects of AST and conducts research on relevant literature from 2003 to 2023. The findings indicate that AST demonstrates promising anti-inflammatory potential in various models of inflammatory diseases. Specifically, AST is believed to possess inhibitory effects on inflammation-related factors and protein levels in various in vitro cell models, such as macrophages, microglia, and epithelial cells. In vivo studies have shown that AST effectively alleviates neuroinflammation and brain damage while also exhibiting potential for treating moderate diseases such as depression and stroke; it also demonstrates significant anti-inflammatory effects on both large and small intestinal epithelial cells. Animal experiments have further demonstrated that AST exerts therapeutic effects on colitis mice. Molecular biology studies have revealed that AST regulates complex signaling networks, including NF-κB, MAPK, JAK/STAT pathways, etc. In conclusion, this review will provide insights and references for the development of AST as an anti-inflammatory agent as well as for related drug development.Keywords
Funding Information
- National Natural Science Foundation of China (82074118, 82104369, 23ZYJDSS00030)
- Science and Technology program of Tianjin in China (82074118, 82104369, 23ZYJDSS00030)
This publication has 105 references indexed in Scilit:
- Astragalin attenuates depression-like behaviors and memory deficits and promotes M2 microglia polarization by regulating IL-4R/JAK1/STAT6 signaling pathway in a murine model of perimenopausal depressionPsychopharmacology, 2022
- Astragalin attenuates oxidative stress and acute inflammatory responses in carrageenan-induced paw edema in miceMolecular Biology Reports, 2020
- OVA-Induced Allergic Airway Inflammation Mouse Model2018
- Inhibitory Effects of Emodin, Thymol, and Astragalin on Leptospira interrogans-Induced Inflammatory Response in the Uterine and Endometrium Epithelial Cells of MiceInflammation, 2017
- Signaling via the NFκB systemWIREs Mechanisms of Disease, 2016
- Astragalin Attenuates Allergic Inflammation in a Murine Asthma ModelInflammation, 2015
- Inhibitory effect of astragalin on expression of lipopolysaccharide-induced inflammatory mediators through NF-κB in macrophagesArchives of Pharmacal Research, 2011
- Isolation and anti-inflammatory effect of astragalin synthesized by enzymatic hydrolysis of tea seed extractJournal of the Science of Food and Agriculture, 2011
- Antiinflammatory activities of flavonoids and a triterpene caffeate isolated fromBauhinia variegataPhytotherapy Research, 2008
- Transformed human bronchial epithelial cells (beas-2b) alter the growth and morphology of normal human bronchial epithelial cells in vitroCell Biology and Toxicology, 1990